?> Contact us Follow Us
Biosimilars Forum
  • About Us
    • Members
    • Executive Director
  • Why Biosimilars
    • The Issue
    • Our Solutions
  • Biosimilars 101
    • Foundations
    • Core Principles
    • FDA Regulatory Tenets
    • Biosimilars FAQs
    • Future Evolution of Biosimilar Development
    • Approved Biosimilars
  • Advocacy
    • Our Action
    • Tools
  • News
  • Resources
  • Get Involved
    • Partners

News

Get more out of your business.
Reach it with Microsoft Dynamics 365 Business Central.
News
October 21, 2021 signalgroup
Biosimilars Forum Member Spotlight: 5 Questions for Samsung Bioepis
News
October 20, 2021 signalgroup
First Biosimilar to Treat Eye Disease Gains FDA Approval
News
October 20, 2021 Katie Quinn
Biosimilars Forum Applauds FDA’s Approval of Second Interchangeable Biosimilar
News
October 13, 2021 Katie Quinn
New Report Finds Biosimilars Could Save States Billions of Dollars Annually
News
September 20, 2021 signalgroup
Senator Wyden, fulfill your promise to lower drug costs for Oregonians by increasing access to next generation generics known as biosimilars
News
September 20, 2021 signalgroup
Senator Carper, fulfill your promise to lower drug costs for Delawareans by increasing access to next generation generics known as biosimilars
News
September 9, 2021 signalgroup
Biden Administration’s Plan to Lower Prescription Drug Prices Supports Biosimilar Competition, which will Decrease Drug Costs
News
August 12, 2021 signalgroup
President Biden’s Plan to Lower Drug Prices Highlights Need for Competition from Biosimilars
News
August 11, 2021 signalgroup
Biosimilars Forum Member Spotlight: 5 Questions for Organon
News
July 29, 2021 signalgroup
FDA’s Approval of First Interchangeable Biosimilar Product Paves Way for Lower Health Care Costs for Patients
  • Prev page
  • 05
  • 06
  • 07
  • 08
  • 09
  • Next page

  • Biosimilars 101
  • Biosimilars FAQs
  • Advocacy
  • Stay Connected
Biosimilars Forum
© 2025 Biosimilars Forum. All rights reserved.
  • Terms of Use
  • |
  • Privacy Policy
  • |
  • Contact Us